Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 7Completed 5Active not recruiting 4Not yet recruiting 2Terminated 1

Sponsor Class

OTHER 5

Study Type

Observational 3Interventional 2

Sponsor

Cancer Type

Breast 5

Conditions

Breast Neoplasms 3Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Breast Cancer Invasive 1Breast Cancer Female 1

Interventions

pembrolizumab 244Nivolumab 140Cisplatin 135Cyclophosphamide 134Paclitaxel 113Carboplatin 108Gemcitabine 98Radiotherapy 83Dexamethasone 83Docetaxel 77atezolizumab 68Ipilimumab 68Doxorubicin 62Fluorouracil 60Blood Specimen Collection 58Bevacizumab 58fludarabine 54Rituximab 54Etoposide 53Oxaliplatin 52Surveys and Questionnaires 49Lenalidomide 49Prednisone 47Standard of Care 45Magnetic Resonance Spectroscopy 45Cetuximab 44Capecitabine 44lenvatinib 43Radiosurgery 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Mastectomy × 1 year × Clear all
NCT03627988 2026-05-22

MARTA

Institut Claudius Regaud

Phase 2 Completed
66 enrolled
Breast

Breast Cancer Invasive

NCT02348684 2026-04-01

Evaluate Cardiac Function Using Cardiac MRI and Dosimetric Correlation

Medical College of Wisconsin

Completed
20 enrolled 5 charts
Breast

Breast Neoplasms

NCT05527769 2026-02-13

DREAM-RMI

Institut Cancerologie de l'Ouest

Completed
27 enrolled
Breast

Breast Cancer Female

NCT01796197 2026-02-05

Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa

Dana-Farber Cancer Institute

Phase 2 Completed
23 enrolled 10 charts
Breast

Breast Neoplasms

NCT01841749 2025-09-12

CINNAMOME

Institut Bergonié

Completed
228 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡